Drug Enforcement Administration (DEA)

Rule Changes

Must run the hearing-driven process and issue any final scheduling rule

Trump’s executive order instructing DOJ to fast-track marijuana’s move to Schedule III immediately triggered a familiar split-screen: public health and industry groups cheered the potential research and tax impacts, while House Republicans organized opposition, urging Trump to keep marijuana in Schedule I.

Updated Dec 18, 2025

Rule Changes

Issued the final rule placing 4-CMC in Schedule I under the CSA

4-CMC is one of those modern drug-market products built for speed: cheap, tweakable chemistry that can be sold as a “new” stimulant the moment the old one gets banned. On December 17, 2025, the U.S. finally snapped the trap shut—DEA’s Schedule I controls for 4-CMC took effect nationwide.

Updated Dec 17, 2025